Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM

International Myeloma Foundation


Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM

Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM